PEACCEL mentioned as a AI start-up to watch by NVIDIA.Three Trends for Healthcare AI Startups To Watch Renee Y. | 19 mars 2021
https://www.linkedin.com/pulse/three-trends-healthcare-ai-startups-watch-renee-yao
Author: adminds
PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021: Market report by Cision (NYSE: CISN).
PEACCEL listed in the Global AI-based Drug Discovery Market Report 2021: Market report by Cision (NYSE: CISN).
PEACCEL awarded by Wealth & Finance
PEACCEL has just received two Artificial Intelligence Awards from Wealth & Finance :
– Best Drug Development AI Partner 2020
– Most Innovative Clinical Data Science Platform : innov’SAR
PEACCEL awarded by CIO Review
PEACCEL has just been nominated as most promising biotech solutions providers in Europe 2021.
Click the links below for more details:
PRAXISforum Enzymes for Industrial Applications 2020, 4-5 February 2020, Frankfurt, Germany
Meet PEACCEL at PRAXISforum Enzymes for Industrial Applications 2020.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
Protein Engineering Congress EU, 12-13 November 2019, Frankfurt am Main, Germany
Meet PEACCEL at Protein Engineering Congress EU.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
Enzyme Engineering XXV, 15-19 September 2019, Whistler, British Columbia, Canada
Meet PEACCEL at Enzyme Engineering XXV.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
14th International Symposium on Biocatalysis and Biotransformations (BioTrans 2019), 7–11 July 2019, Groningen, The Netherlands
Meet PEACCEL at the Biotrans 2019.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
PEACCEL secures new funding.
PEACCEL’s “Development of polypeptides by protein design” R&D program aims to develop a virtual platform for obtaining polypeptides with superior capacities, for the pharmaceutical and chemical industries.
Results: Virtual platform, proprietary molecules, POCs, and extension of international partnerships.
Annual Conference 2019 of the Association for General and Applied Microbiology, 17–20 March 2019, Mainz, Germany
Meet PEACCEL at the VAAM 2019.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
PEACCEL will give a presentation “innov’SAR: a new approach for protein engineering and screening” on March 18 between 18:00-18:30.